Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function
ST. GALLEN, Switzerland & UNIONDALE, NY -- (BUSINESS WIRE) -- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho......
